Host-microbe interactions shaping the gastrointestinal environment

Trends in Immunology

Volumn 35, Issue 11, 2014, Pages 538-548

  Kaiko, Gerard E ^a   Stappenbeck, Thaddeus S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epithelial barrier; Host microbial interaction; Intestinal pathogen; Metabolism

Indexed keywords

IMMUNOGLOBULIN A; POLYPEPTIDE ANTIBIOTIC AGENT;

COMMENSAL; GASTROINTESTINAL TRACT; HOMEOSTASIS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATORY DISEASE; INTESTINAL BARRIER; INTESTINE FLORA; INTESTINE FUNCTION; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MICROBIAL IMMUNITY; MICROBIAL METABOLISM; NONHUMAN; PATHOGEN LOAD; PERMEABILITY BARRIER; PHYSICAL RESISTANCE; REVIEW; ANIMAL; DISEASE PREDISPOSITION; IMMUNOLOGY; INTESTINE MUCOSA; MICROBIOLOGY; MICROFLORA; MUCOSAL IMMUNITY; PHYSIOLOGY;

ANIMALS; DISEASE SUSCEPTIBILITY; GASTROINTESTINAL TRACT; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, MUCOSAL; INTESTINAL MUCOSA; MICROBIOTA;

EID: 84920469791     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.08.002     Document Type: Review

References (108)

1. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214. Human Microbiome Project Consortium.
2. A framework for human microbiome research. Nature 2012, 486:215-221. Human Microbiome Project Consortium.
3. Hooper L.V., Macpherson A.J. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat. Rev. Immunol. 2010, 10:159-169.
4. Lee W.J., Hase K. Gut microbiota-generated metabolites in animal health and disease. Nat. Chem. Biol. 2014, 10:416-424.
5. Hansson G.C. Role of mucus layers in gut infection and inflammation. Curr. Opin. Microbiol. 2012, 15:57-62.
6. Kaetzel C.S. Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism. Immunol. Lett. 2014, 10.1016/j.imlet.2014.05.008.
7. Salzman N.H., Bevins C.L. Dysbiosis - a consequence of Paneth cell dysfunction. Semin. Immunol. 2013, 25:334-341.
8. Faust K., Raes J. Microbial interactions: from networks to models. Nat. Rev. Microbiol. 2012, 10:538-550.
9. Hasegawa M., et al. Transitions in oral and intestinal microflora composition and innate immune receptor-dependent stimulation during mouse development. Infect. Immun. 2010, 78:639-650.
10. Matamoros S., et al. Development of intestinal microbiota in infants and its impact on health. Trends Microbiol. 2013, 21:167-173.
11. Cotillard A., et al. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588.
12. Adlerberth I., et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle?. Pediatr. Res. 2006, 59:96-101.
13. Benno Y., et al. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol. Immunol. 1984, 28:975-986.
14. Cummings J.H., et al. Digestion and physiological properties of resistant starch in the human large bowel. Br. J. Nutr. 1996, 75:733-747.
15. Lee S.M., et al. Bacterial colonization factors control specificity and stability of the gut microbiota. Nature 2013, 501:426-429.
16. Ng K.M., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
17. Koropatkin N.M., et al. How glycan metabolism shapes the human gut microbiota. Nat. Rev. Microbiol. 2012, 10:323-335.
18. Mortensen P.B., Nordgaard-Andersen i The dependence of the in vitro fermentation of dietary fibre to short-chain fatty acids on the contents of soluble non-starch polysaccharides. Scand. J. Gastroenterol. 1993, 28:418-422.
19. Martinez I., et al. Resistant starches types 2 and 4 have differential effects on the composition of the fecal microbiota in human subjects. PLoS ONE 2010, 5:e15046.
20. Walker A.W., et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J. 2011, 5:220-230.
21. Wu G.D., et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334:105-108.
22. David L.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014, 505:559-563.
23. De Filippo C., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:14691-14696.
24. Rawls J.F., et al. Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 2006, 127:423-433.
25. Favier C.F., et al. Molecular monitoring of succession of bacterial communities in human neonates. Appl. Environ. Microbiol. 2002, 68:219-226.
26. Harmsen H.J., et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J. Pediatr. Gastroenterol. Nutr. 2000, 30:61-67.
27. Mariat D., et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 2009, 9:123.
28. Sela D.A. Bifidobacterial utilization of human milk oligosaccharides. Int. J. Food Microbiol. 2011, 149:58-64.
29. Sela D.A., et al. An infant-associated bacterial commensal utilizes breast milk sialyloligosaccharides. J. Biol. Chem. 2011, 286:11909-11918.
30. Fuhrer A., et al. Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J. Exp. Med. 2010, 207:2843-2854.
31. Mahowald M.A., et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5859-5864.
32. Wrzosek L., et al. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 2013, 11:61.
33. Rakoff-Nahoum S., et al. An ecological network of polysaccharide utilization among human intestinal symbionts. Curr. Biol. 2014, 24:40-49.
34. Benson A.K., et al. Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:18933-18938.
35. Eckburg P.B., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
36. Nava G.M., et al. Spatial organization of intestinal microbiota in the mouse ascending colon. ISME J. 2011, 5:627-638.
37. Arumugam M., et al. Enterotypes of the human gut microbiome. Nature 2011, 473:174-180.
38. Caporaso J.G., et al. Moving pictures of the human microbiome. Genome Biol. 2011, 12:R50.
39. Croswell A., et al. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect. Immun. 2009, 77:2741-2753.
40. Ayres J.S., et al. Lethal inflammasome activation by a multidrug-resistant pathobiont upon antibiotic disruption of the microbiota. Nat. Med. 2012, 18:799-806.
41. Marteyn B., et al. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 2010, 465:355-358.
42. Cherrington C.A., et al. Short-chain organic acids at pH 5.0 kill Escherichia coli and Salmonella spp. without causing membrane perturbation. J. Appl. Bacteriol. 1991, 70:161-165.
43. Fukuda S., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
44. Shin R., et al. Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J. Med. Microbiol. 2002, 51:201-206.
45. Gantois I., et al. Butyrate specifically down-regulates Salmonella pathogenicity island 1 gene expression. Appl. Environ. Microbiol. 2006, 72:946-949.
46. Cotter P.D., et al. Bacteriocins - a viable alternative to antibiotics?. Nat. Rev. Microbiol. 2013, 11:95-105.
47. Schamberger G.P., Diez-Gonzalez F. Selection of recently isolated colicinogenic Escherichia coli strains inhibitory to Escherichia coli O157:H7. J. Food Prot. 2002, 65:1381-1387.
48. Fabich A.J., et al. Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Infect. Immun. 2008, 76:1143-1152.
49. Kamada N., et al. Regulated virulence controls the ability of a pathogen to compete with the gut microbiota. Science 2012, 336:1325-1329.
50. Brandl K., et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008, 455:804-807.
51. Endt K., et al. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog. 2010, 6:e1001097.
52. Brandt L.J., et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am. J. Gastroenterol. 2012, 107:1079-1087.
53. Theriot C.M., et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 2014, 5:3114.
54. Bloom S.M., et al. Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe 2011, 9:390-403.
55. Garrett W.S., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 2010, 8:292-300.
56. Maier L., et al. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe 2013, 14:641-651.
57. Winter S.E., et al. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 2010, 467:426-429.
58. Levitt M.D., et al. Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa. J. Clin. Invest. 1999, 104:1107-1114.
59. Gevers D., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014, 15:382-392.
60. Morgan X.C., et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012, 13:R79.
61. Magin W.S., et al. Immunohistochemical search for viral and bacterial antigens in Crohn's disease. J. Crohns Colitis 2013, 7:161-166.
62. Negroni A., et al. Characterization of adherent-invasive Escherichia coli isolated from pediatric patients with inflammatory bowel disease. Inflamm. Bowel Dis. 2012, 18:913-924.
63. Winter S.E., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
64. Cerutti A. The regulation of IgA class switching. Nat. Rev. Immunol. 2008, 8:421-434.
65. Moreau M.C., et al. Increase in the population of duodenal immunoglobulin A plasmocytes in axenic mice associated with different living or dead bacterial strains of intestinal origin. Infect. Immun. 1978, 21:532-539.
66. Hapfelmeier S., et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010, 328:1705-1709.
67. Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665.
68. Wesemann D.R., et al. Microbial colonization influences early B-lineage development in the gut lamina propria. Nature 2013, 501:112-115.
69. Bessa J., Bachmann M.F. T cell-dependent and -independent IgA responses: role of TLR signalling. Immunol. Invest. 2010, 39:407-428.
70. Johansen F.E., et al. Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice. J. Exp. Med. 1999, 190:915-922.
71. Wei M., et al. Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Nat. Immunol. 2011, 12:264-270.
72. + T cells regulate immunoglobulin A selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 2014, 41:152-165.
73. Gallo R.L., Hooper L.V. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 2012, 12:503-516.
74. Cash H.L., et al. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 2006, 313:1126-1130.
75. Kagan B.L., et al. Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:210-214.
76. Gunn J.S., et al. Genetic and functional analysis of a PmrA-PmrB-regulated locus necessary for lipopolysaccharide modification, antimicrobial peptide resistance, and oral virulence of Salmonella enterica serovar Typhimurium. Infect. Immun. 2000, 68:6139-6146.
77. Islam D., et al. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat. Med. 2001, 7:180-185.
78. O'Neil D.A., et al. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 1999, 163:6718-6724.
79. Hooper L.V., et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 2003, 4:269-273.
80. Becker S., et al. Bacteria regulate intestinal epithelial cell differentiation factors both in vitro and in vivo. PLoS ONE 2013, 8:e55620.
81. Brandl K., et al. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. J. Exp. Med. 2007, 204:1891-1900.
82. Vaishnava S., et al. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:20858-20863.
83. Vaishnava S., et al. The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 2011, 334:255-258.
84. Petnicki-Ocwieja T., et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15813-15818.
85. Schauber J., et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003, 52:735-741.
86. Schroeder B.O., et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011, 469:419-423.
87. Kinnebrew M.A., et al. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J. Infect. Dis. 2010, 201:534-543.
88. Salzman N.H., et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 2010, 11:76-83.
89. Meyer-Hoffert U., et al. Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut 2008, 57:764-771.
90. Philpott A., Winton D.J. Lineage selection and plasticity in the intestinal crypt. Curr. Opin. Cell Biol. 2014, 31C:39-45.
91. Hamer H.M., et al. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27:104-119.
92. Maslowski K.M., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
93. Smith P.M., et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.
94. Blad C.C., et al. G protein-coupled receptors for energy metabolites as new therapeutic targets. Nat. Rev. Drug Discov. 2012, 11:603-619.
95. Galvez J., et al. Effects of dietary fiber on inflammatory bowel disease. Mol. Nutr. Food Res. 2005, 49:601-608.
96. Pedron T., et al. A crypt-specific core microbiota resides in the mouse colon. mBio 2012, 3:e00116-e212.
97. Buchon N., et al. Drosophila intestinal response to bacterial infection: activation of host defense and stem cell proliferation. Cell Host Microbe 2009, 5:200-211.
98. Jones R.M., et al. Symbiotic lactobacilli stimulate gut epithelial proliferation via Nox-mediated generation of reactive oxygen species. EMBO J. 2013, 32:3017-3028.
99. Guo L., et al. PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan. Cell 2014, 156:109-122.
100. Van der Sluis M., et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006, 131:117-129.
101. Kandori H., et al. Histochemical, lectin-histochemical and morphometrical characteristics of intestinal goblet cells of germfree and conventional mice. Exp. Anim. 1996, 45:155-160.
102. Enss M.L., et al. Changes in colonic mucins of germfree rats in response to the introduction of a "normal" rat microbial flora. Rat colonic mucin. J. Exp. Anim. Sci. 1992, 35:110-119.
103. Langille M.G., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 2013, 31:814-821.
104. Le Chatelier E., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500:541-546.
105. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
106. Barker N., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
107. Miyoshi H., et al. Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science 2012, 338:108-113.
108. Cammarota G., et al. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J. Clin. Gastroenterol. 2014, 48:693-702.